Current Oncology, Free Full-Text
Por um escritor misterioso
Last updated 31 maio 2024
Background: Information on immune responses in cancer patients following mRNA COVID-19 vaccines is still insufficient, but generally, patients had impaired serological responses, especially those with hematological malignancies. We evaluated serological response to COVID-19 mRNA vaccine in cancer patients receiving chemotherapy compared with healthy controls. Methods: In total, 195 cancer patients and 400 randomly selected controls who had been administered a Pfizer-BioNTech or Moderna COVID-19 vaccines in two doses were compared. The threshold of positivity was 4.33 BAU/mL. Patients were receiving anticancer treatment after the first and second dose of the vaccines. Results: a TOTAL OF 169 patients (87%) had solid tumors and 26 hemolymphopoietic diseases. Seropositivity rate was lower in patients than controls (91% vs. 96%), with an age/gender-adjusted rate ratio (RR) of 0.95 (95% CL = 0.89–1.02). Positivity was found in 97% of solid cancers and in 50% of hemolymphopoietic tumors. Both advanced and adjuvant therapy seemed to slightly reduce seropositivity rates in patients when compared to controls (RR = 0.97, 95% CL = 0.89–1.06; RR = 0.94, 95% CL = 0.87–1.01). Conclusions: the response to vaccination is similar in patients affected by solid tumors to controls. On the contrary, hemolymphopietic patients show a much lower response than controls.
Remission, cancer-free, no evidence of disease: What's the difference?
Cancer treatment and survivorship statistics, 2022 - Miller - 2022 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Finding Mr. Destiny Arabic Sub - Colaboratory
GU Oncology Now
Nepalese Journal of Ophthalmology
Malignant: How Bad Policy and Bad by Prasad, Vinayak K.
Journal of Current Oncology: Sage Journals
Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs - The Lancet Oncology
Dewa Regulations 2017 Free Download - Colaboratory
Current Oncology An Open Access Journal from MDPI
Home Page: Clinical Lymphoma, Myeloma and Leukemia
Cancer Support Groups, Counseling, Education & Financial Assistance
Current Oncology An Open Access Journal from MDPI
Electric Fields Disrupt Cancer Cell Division
Recomendado para você
-
In Memoriam: Remembering Gustav Meier – Peabody Magazine31 maio 2024
-
Bronstein popular -_exames_a_preços_populares31 maio 2024
-
Bronstein: Agendamento online de exames e vacinas pelo Nav31 maio 2024
-
EM FRENTE AO LABORATÓRIO BRONSTEIN - MGF Imóveis - MGF Imóveis31 maio 2024
-
Meet the Defamation Lawyer Combating Online Harassment Campaigns31 maio 2024
-
Assistência 1031 maio 2024
-
AUTHOR - Andrew Meier - The Hampton Synagogue31 maio 2024
-
Game of the Week: Banikas vs Meier31 maio 2024
-
The diagnostic accuracy and clinical impact of FDG-PET/CT follow31 maio 2024
-
Peruvian hassidic Jew moves to Israel, gains large following - The Jerusalem Post31 maio 2024
você pode gostar
-
The Last Of Us Part 1 Review31 maio 2024
-
Overlord IV Limited Edition Box Set Release Date Revealed31 maio 2024
-
Belle Delphine Memes31 maio 2024
-
Kids Play Images – Browse 1,503 Stock Photos, Vectors, and Video31 maio 2024
-
Agenda da Varzea – Dia da Consciência Negra e fim-de-semana – 2031 maio 2024
-
Pain Hustlers (2023) - IMDb31 maio 2024
-
Resident Evil 4 Remake - Ashley Moon Light Puzzle Solution - Mausoleum Chapter 931 maio 2024
-
Desenhos para colorir lol surpresa como faço, trabalhos manuais31 maio 2024
-
🎀 Femboy of The Day 🎀 on X: Today's Femboy is Periwinkle from First Kiss at a Spooky Soiree! 🎀 / X31 maio 2024
-
Enquete A Fazenda 14: Vini, Bia, Bárbara e Tati estão na roça31 maio 2024